Dr Ajai Chari Highlights Advances in Multiple Myeloma
Multiple myeloma can be an extremely complex disease to understand and navigate through. To help patients and their loved ones become equipped with the knowledge needed to manage the journey that lies ahead, CURE Connections has made available this special video series which features expert insight from Ajai Chari, MD, an associate professor of medicine for hematology and medical oncology and director of clinical research for the Multiple Myeloma Program at Mount Sinai Hospital.
▼ Episode 1 Types of Multiple Myeloma
Dr. Ajai Chari explains how multiple myeloma forms and details each stage of the disease to help patients and loved ones better understand how disease progression is weighed weighs into a clinician’s decision about treatment.
Dr Ajai Chari discusses the most common concerns of patients and their loved ones following a diagnosis of multiple myeloma, and explains how he works with them to understand their options for treatment. He also provides a brief overview of available treatment options and goals of therapy based on a diagnosis.
Dr Ajai Chari remarks on some of the common side effects that may occur during or after treatment, and explains how healthcare professionals monitor and work with patients to manage them. He also explains the role of diagnostic testing in evaluating treatment response.
► Episode 5 Top Considerations for Maintenance Therapy
Following his discussion on the management of side effects that may occur throughout treatment, Dr Ajai Chari explains what maintenance therapy is and when it is appropriate in multiple myeloma. He also suggests supportive care options and techniques for patients undergoing stem cell transplantation.
► Episode 7 Clinical Trials and Stem Cell Transplants
In some instances, a patient with multiple myeloma may be eligible for a stem cell transplant or participation in a clinical trial. Dr Ajai Chari discusses the role of each option, highlights when each option may be appropriate, and explores some common misconceptions surrounding both topics.
Dr Ajai Chari remarks on the recent evolution of a number of drugs entering the market for the treatment of multiple myeloma, cites studies that are testing the effectiveness of early transplantation in different groups of patients, and discusses the potential impact of research on future treatment of the disease.